1st Meeting of the Drug Safety and Effectiveness Network Steering Committee (DSEN SC) - Agenda

Agenda

Meeting: 1st Meeting of the Drug Safety and Effectiveness Network Steering Committee (DSEN SC)
Date: Friday, September 17th, 2010
Time: 8:30 am – 4:30 pm
Location: CIHR Offices, 160 Elgin Street, 9th Floor, Ottawa, Ontario - Room 9-101
Dial-in: 613-960-7513 (direct number); 1-877-413-4788 (toll free)
Passcode: 30-80-864#
Chair: Graham, Ian (Canadian Institutes of Health Research)
Members:
  • Ballantyne, Meena (Health Canada)
  • Berthelot, Jean-Marie (Canadian Institute for Health Information)
  • Gray, Jean (Dalhousie University)
  • Hoffman, Abby (Health Canada)
  • Laupacis, Andreas (University of Toronto)
  • McArthur, Diane (Ontario Public Drug Programs)
  • Nakagawa, Bob (British Columbia Ministry of Health)
  • O'Rourke, Brian (Canadian Agency for Drugs and Technologies in Health)
  • Peterson, Robert (Ex-officio, Canadian Institutes of Health Research)
  • Robitaille, Lucie (Québec Ministry of Health and Social Services)
  • Turner, Chris (Health Canada)
  • Wells, Diane (Nurse and Health IT Consultant, Saskatchewan)
  • Wilhelm, Linda (Patient Advocate)
Invited Experts: Roos, Noralou (Manitoba Centre for Health Policy)
Secretariat:
  • Brochu, Christian; 
  • Condran, Gary; 
  • Delage, Joane; 
  • Yasari, Siham

 

Time Description Information / Discussion/ Decision Lead
8:30 Continental breakfast    
9:00 1. Call to Order and Welcoming:
Welcoming and Introductions Objectives of the Meeting Approval of the Agenda Reaffirmation of the Conflict of Interest Statements Review of the DSEN SC Terms of Reference 		Decision Discussion Decision Ian Graham
9:30 2. DSEN Overview and Progress Update Information Robert Peterson
10:15 Health Break    
10:30 3. DSEN Funding Opportunities: Catalysts Grants Collaborating Centre for Observational Studies (CCOS) Collaborating Centres for Prospective Surveillance and Pharmacoepidemiological Studies (CCPSPS) Collaborating Centres for RCTs, Systematic Reviews, and Indirect Comparisons (CCRSI) Information Robert Peterson
11:15 4. DSEN and Real World Safety and Efficacy, examples of opportunities for: Discussion  
  the Research Community (10-15 min.)    
  Health Canada (10-15 min.)    
  the End Users (10-15 min.)    
12:00 Lunch (provided)    
13:00 5. DSEN Initiatives and Knowledge Translation (KT): National activities: DSEN Collaborative Innovation Forum (November 2010) Réseau Québécois de recherche sur l'usage des médicaments (RQRUM) Canadian Agency for Drugs and Technologies in Health (CADTH) International activities*: FDA's Sentinel Initiative, Fnih's omop, EMEA's ENCePP and PROTECT Initiatives Information Ian Graham / Robert Peterson
14:00 6. Strategic Operations and Directions: Overview of Procedures and Considerations for the Identification, Prioritization and Management of DSEN Queries DSEN Advisory Committees: Science Advisory Committee (SAC) Data Management Advisory Committee (DMAC) Collaborating Centres Advisory Committee (CCAC) Discussion All
  Health Break (15 min.)    
  6. Strategic Operations and Directions (continued): Ensuring appropriate attention afforded to DSEN queries/requests for data Strategies for Effective Dissemination and Optimal Utilization    
16:15 7. Next Steps / DSEN SC Meeting Schedule   Ian Graham
16:30 Meeting Adjournment    

* Acronyms:

FDA's Sentinel Initiative: Food and Drug Administration Sentinel Initiative

FNIH's OMOP: Foundation for the National Institutes of Health's (FNIH) Observational Medical Outcomes Partnership (OMOP)

EMEA's ENCePP: EMEA's European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

EMEA's PROTECT: EMEA's Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)

Supplemental content (right column)